Purpose Monitoring of residual disease (RD) by flow cytometry in childhood acute myeloid leukemia (AML) may predict outcome. However, the optimal time points for investigation, the best antibody ...

Artificial intelligence may be leveraged to improve minimal residual disease measurements for ... including AML. High-sensitivity flow cytometry is the most common technique to detect circulating ...

Through this collaboration, LabPMM (Invivoscribe’s global reference laboratories) have customized their multiparametric flow cytometry (MFC) services and implemented their sensitive MFC AML MRD ...

Through this collaboration, LabPMM (Invivoscribe’s global reference laboratories) have customized their multiparametric flow cytometry (MFC) services and implemented their sensitive MFC AML MRD ...

Minimal residual disease ... MRD is measured 2 ways: Flow cytometry evaluates cell characteristics, ... of patients who were MRD positive. 58% (115) had TEL-AML-negative disease versus 42% ...

In this video, Eunice Wang, MD, Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center, discusses the major challenges surrounding identification and treatment of relapsed acute ...

A correlation exists between MRD and the risk of relapse in patients with de novo AML after induction therapy and before hematopoietic cell transplantation. This study did not confirm the impact ...